Infection Surveillance Solutions Market Size (2024 - 2029)

The Infection Surveillance Solutions Market is experiencing growth driven by stringent government policies aimed at preventing hospital-associated infections, which pose significant challenges in healthcare. The increasing number of surgeries, which heightens the risk of surgical site infections, further propels the demand for these solutions. Regulatory requirements also mandate healthcare facilities to implement infection surveillance systems, contributing to the market's expansion. Despite these drivers, the adoption of technology in healthcare is often hindered by concerns over liability, funding, and the pace of change.

Market Size of Infection Surveillance Solutions Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Infection Surveillance Solutions Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 0.63 Billion
Market Size (2029) USD 1.20 Billion
CAGR (2024 - 2029) 13.87 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Infection Surveillance Solutions Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Infection Surveillance Solutions Market Analysis

The Infection Surveillance Solutions Market size is estimated at USD 0.63 billion in 2024, and is expected to reach USD 1.20 billion by 2029, growing at a CAGR of 13.87% during the forecast period (2024-2029).

  • Stringent government policies for preventing hospital-associated infections are aiding in developing analytical and infection surveillance solutions for application in the healthcare industry. Hospital-acquired infections are a major cause of mortality and morbidity and provide a challenge to clinicians.
  • The US Department of Health and Human Services released the 'National Action Plan to Prevent Health Care-Associated Infections: Road Map to Elimination (HAI Action Plan),' outlining specific five-year goals for the prevention of healthcare-associated infections. Additionally, the World Health Organization (WHO) developed a protocol for implementing the Surgical Unit-based Safety Programme in African hospitals.
  • Moreover, the rise in the number of surgeries is also one of the drivers of the market, as with surgery, surgical site infections (SSIs) represent a substantial clinical and economic burden on patients and the healthcare system. The prevention of SSIs entails surveillance activities. According to the Lancet Commission for Global Surgery (LCoGS), 11% of the global burden of the disease requires surgical care, anesthesia management, or both. Some studies have estimated this burden to be as high as 30%. The LCoGS estimated that 5,000 surgeries are required to meet the surgical burden of disease for 100,000 people in LMICs (low-to-middle-income countries).
  • Surgical site infections are not just a problem for poor countries; in the United States, they contribute to patients spending more than 400,000 extra days in hospital at the cost of an additional USD 10 billion per year (source: WHO).
  • However, Healthcare providers are often reluctant to engage with technology, partly due to the scale and pace of changes and partly through lack of education and training and concerns over liability and funding.
  • Moreover, many healthcare facilities are required by regulatory bodies to have infection surveillance solutions in place. For instance, the International Health Regulations (2005) (IHR 2005) require countries to designate a National IHR Focal Point for communications with WHO to establish and maintain core capacities for surveillance and response, including at designated points of entry.

Infection Surveillance Solutions Industry Segmentation

The demand for infection surveillance has been on the rise as the need to curb hospital-acquired infections and other epidemics is intensifying. Infection surveillance solutions are designed to continuously monitor and interpret health data to ensure accurate implementation of preventive measures. The major factors contributing to the growth of this market include an increase in the incidence of HAIs and a growth in the number of surgeries coupled with government protocols for the prevention of HAIs.

The infection surveillance solutions market is segmented by offering (software and services), end-user (hospitals, long-term care facilities, and other end-users), and geography (Europe, Asia-Pacific, and the Rest of the World). The report offers market forecasts and size in value (USD) for all the above segments.

By Offering
Software
On-Premise
Cloud
Services
Maintenance and Support
Consultation and Training
Implementation Service
By End-User
Hospitals
Long-term Care Facilities
Other End Users
By Geography***
North America
United States
Canada
Europe
United Kingdom
Germany
France
Italy
Spain
Asia
China
India
Japan
Australia and New Zealand
Latin America
Middle East and Africa
Need A Different Region Or Segment?
Customize Now

Infection Surveillance Solutions Market Size Summary

The Infection Surveillance Solutions Market is poised for significant growth, driven by stringent government policies aimed at preventing hospital-associated infections and the increasing number of surgeries worldwide. These factors have led to a heightened demand for analytical and surveillance solutions within the healthcare sector. The market is further bolstered by initiatives from organizations such as the US Department of Health and Human Services and the World Health Organization, which have set forth plans and protocols to reduce healthcare-associated infections. Despite the challenges healthcare providers face in adopting new technologies, regulatory requirements and the need for effective infection control measures are propelling the market forward. The importance of maintenance and support services, particularly in post-surgical settings, underscores the critical role of surveillance solutions in mitigating infections and improving patient outcomes.

North America stands out as a major player in the Infection Surveillance Solutions Market, with the United States leading due to its robust research and development activities in medical sciences. Government initiatives and the high incidence of healthcare-associated infections are key drivers in this region. The market is characterized by intense competition among global players, who are focusing on product innovation, strategic partnerships, and acquisitions to maintain their competitive edge. Recent advancements, such as GAMA Healthcare's infection prevention solutions and Wolters Kluwer's Sentri Sepsis Monitor, highlight the ongoing efforts to enhance infection surveillance capabilities. Additionally, international collaborations, like the one between GSK plc and Microsoft in Nepal, demonstrate the global commitment to leveraging technology in combating infectious diseases. These dynamics are shaping the market landscape, fostering growth and technological advancements in infection surveillance solutions.

Explore More

Infection Surveillance Solutions Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Stringent Government Policies for Preventing Hospital Associated Infections

      2. 1.2.2 Rise in the Number of Surgeries

    3. 1.3 Market Restraints

      1. 1.3.1 Reluctance Among Medical Professionals to Adopt Advanced Healthcare Tools

    4. 1.4 Industry Value Chain Analysis

    5. 1.5 Industry Attractiveness - Porter's Five Forces Analysis

      1. 1.5.1 Threat of New Entrants

      2. 1.5.2 Bargaining Power of Buyers/Consumers

      3. 1.5.3 Bargaining Power of Suppliers

      4. 1.5.4 Threat of Substitute Products

      5. 1.5.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Offering

      1. 2.1.1 Software

        1. 2.1.1.1 On-Premise

        2. 2.1.1.2 Cloud

      2. 2.1.2 Services

        1. 2.1.2.1 Maintenance and Support

        2. 2.1.2.2 Consultation and Training

        3. 2.1.2.3 Implementation Service

    2. 2.2 By End-User

      1. 2.2.1 Hospitals

      2. 2.2.2 Long-term Care Facilities

      3. 2.2.3 Other End Users

    3. 2.3 By Geography***

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

      2. 2.3.2 Europe

        1. 2.3.2.1 United Kingdom

        2. 2.3.2.2 Germany

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

      3. 2.3.3 Asia

        1. 2.3.3.1 China

        2. 2.3.3.2 India

        3. 2.3.3.3 Japan

      4. 2.3.4 Australia and New Zealand

      5. 2.3.5 Latin America

      6. 2.3.6 Middle East and Africa

Infection Surveillance Solutions Market Size FAQs

The Infection Surveillance Solutions Market size is expected to reach USD 0.63 billion in 2024 and grow at a CAGR of 13.87% to reach USD 1.20 billion by 2029.

In 2024, the Infection Surveillance Solutions Market size is expected to reach USD 0.63 billion.

Infection Surveillance Solutions Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)